James Wilson edits the Pharma and Biotech desk at Trend & Ticker. He covers drug developers, clinical trial results, regulatory decisions and the business of pharmaceutical and biotechnology companies. His reporting draws on company releases, trial registries, FDA notices and SEC filings, and he checks each claim and figure against the original document before publication.
Αναζήτηση
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)